4.3 Article

Echinocandin Use in the Neonatal Intensive Care Unit

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Safety and Pharmacokinetics of Multiple-Dose Anidulafungin in Infants and Neonates

M. Cohen-Wolkowiez et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)

Review Pharmacology & Pharmacy

Echinocandin Antifungal Drugs in Fungal Infections A Comparison

Sharon C. -A. Chen et al.

DRUGS (2011)

Article Pharmacology & Pharmacy

A Clinical Review of Echinocandins in Pediatric Patients

Heather L. VandenBussche et al.

ANNALS OF PHARMACOTHERAPY (2010)

Article Pharmacology & Pharmacy

Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants

D. K. Benjamin et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)

Article Pharmacology & Pharmacy

Neonatal Peritoneal Candidiasis Successfully Treated with Anidulafungin Add-On Therapy

Brian Michael Varisco et al.

ANNALS OF PHARMACOTHERAPY (2009)

Article Microbiology

Pharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age

Xavier Saez-Llorens et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Article Obstetrics & Gynecology

Refractory neonatal candidemia and high-dose micafungin pharmacotherapy

G. Natarajan et al.

JOURNAL OF PERINATOLOGY (2009)

Article Immunology

PHARMACOKINETICS OF PROPHYLACTIC MICAFUNGIN IN VERY-LOW-BIRTH-WEIGHT INFANTS

Mayumi Kawada et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)

Article Immunology

Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates

P. Brian Smith et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)

Article Pediatrics

Efficacy of micafungin in treating four premature infants with candidiasis

Chiharu Kawaguchi et al.

PEDIATRICS INTERNATIONAL (2009)

Review Microbiology

Epidemiology of invasive candidiasis: a persistent public health problem

M. A. Pfaller et al.

CLINICAL MICROBIOLOGY REVIEWS (2007)

Article Immunology

The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants

Gloria P. Heresi et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)

Letter Immunology

Caspofungin for refractory candidemia in neonates

S Manzar et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)

Article Microbiology

Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents

TJ Walsh et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

Article Microbiology

Safety, tolerability, and pharmacokinetics of micafungin (FK463) in febrile neutropenic pediatric patients

NL Seibel et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

Article Microbiology

Disposition of caspofungin: Role of distribution in determining pharmacokinetics in plasma

JA Stone et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)

Article Immunology

Risk factors for disseminated candidiasis in children with candidemia

TE Zaoutis et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)

Article Immunology

Risk factors for candidemia in neonatal intensive care unit patients

L Saiman et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)